Director Sharlene’s Zero‑Cash Share Grant Signals Confidence as Simulations Plus Stock Sinks to 52‑Week Low

Insider Buying by Evans Sharlene Signals Confidence Amid Volatile Share Price

On January 30, 2026, Evans Sharlene—an independent director of Simulations Plus Inc.—acquired 1,776 shares of the company’s common stock as compensation under the 2021 Equity Incentive Plan. The purchase was made at zero cash cost, effectively a grant of shares tied to the company’s performance. With the share price hovering at $16.77, this transaction brings Sharlene’s post‑transaction holdings to 15,056 shares, an increase of roughly 1,776 shares from her last trade on November 3, 2025.

The timing of this grant is noteworthy. The stock has slid 52‑week lows and a year‑to‑date decline of 52.76 %, reflecting investor discomfort. Yet Sharlene’s decision to accept additional shares—rather than selling any—suggests she believes the company’s long‑term prospects outweigh short‑term price pressure. The transaction also coincides with a surge in social‑media buzz (129 % above average) and a modestly negative sentiment score (-11), indicating that the market reaction has not yet fully absorbed the director’s confidence.

What This Means for Investors

For shareholders, Sharlene’s buy may serve as a subtle endorsement of the company’s strategic direction. The grant aligns her interests with the equity base, potentially encouraging management to pursue initiatives that increase shareholder value. However, the overall insider activity remains mixed: while Sharlene’s purchase is a bullish sign, other insiders such as Woltosz Walter S and Fiedler‑Kelly Jill have been active buyers and sellers in the same period, reflecting a broader strategy of portfolio rebalancing rather than a unified bullish stance. Investors should weigh the director’s confidence against the company’s weak price performance and negative price‑earnings ratio of -5.29, which signals potential profitability challenges.

Profile of Evans Sharlene

Evans Sharlene’s insider trading history shows a consistent pattern of modest, cash‑free purchases aligned with the company’s equity incentive plans. Her first recorded trade—November 3, 2025—was a 1,771‑share grant that increased her holdings to 13,280 shares. The January 30, 2026 transaction adds 1,776 shares, bringing her total to 15,056. No sales have been recorded, and each transaction has been a grant rather than a market purchase. This disciplined approach indicates a long‑term commitment to the company’s mission and a belief that the current valuation underestimates future value. Her trades are typically executed at zero cost, reflecting a focus on aligning executive compensation with company performance rather than short‑term speculative gains.

Implications for Simulations Plus’ Future

The combination of insider grants and a flurry of other trades suggests that senior management is actively managing their positions, possibly to maintain liquidity and comply with regulatory requirements. Sharlene’s continued accumulation of shares could signal confidence in upcoming product launches or strategic partnerships that may reverse the current downward trend. Meanwhile, the broader insider activity, including significant buys by the CEO and CFO, points to a corporate culture that values equity participation.

For investors, the key takeaways are twofold: first, the director’s purchase may be a vote of confidence that could precede a rebound in the stock price; second, the company’s fundamentals remain weak, with a negative P/E and substantial volatility. Those willing to ride the volatility may find value in the company’s niche technology, but should monitor upcoming earnings reports and product updates closely.